'Pfizer is planning to test a daily weight-loss pill in mid-stage trials later this year, as the struggling pharmaceutical group pins its hope on the experimental drug as its route into a market projected to be worth more than $130bn a year.'

https://www.ft.com/content/865f8432-6c88-40ca-a48e-06b30a81f176